Home/Filings/4/0000885590-15-000074
4//SEC Filing

Valeant Pharmaceuticals International, Inc. 4

Accession 0000885590-15-000074

$BHCCIK 0000885590operating

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 5:01 PM ET

Size

5.4 KB

Accession

0000885590-15-000074

Insider Transaction Report

Form 4
Period: 2015-10-20
Rosiello Robert L.
EVP, Chief Financial Officer
Transactions
  • Award

    Restricted Share Units

    2015-10-20+7,875449,550 total
Footnotes (2)
  • [F1]Represents Restricted Share Units received under an Employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
  • [F2]1/5 of the Matching RSUs will vest each on the first, second, third, fourth and fifth anniversary of the date of grant subject to continued employment and retention of the corresponding purchased shares.

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000885590

Filing Metadata

Form type
4
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 5:01 PM ET
Size
5.4 KB